The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Akshit M Raycha HUF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.5 pts more than Nifty Microcap 250 and 4.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Akshit M Raycha HUF, part of the promoter/promoter group of Achyut Healthcare Limited, has acquired 2,52,000 equity shares representing 0.11% of the company's share capital through open market purchase on September 17, 2025. Post-acquisition, the HUF's holding increased from 26,17,020 shares (1.11%) to 28,69,020 shares (1.22%) of the company. The acquisition was carried out under Regulation 29(2) of SEBI (SAST) Regulations, 2011, and no encumbrance (pledge) was created on the shares. The total equity share capital of the company remains Rs. 23,55,57,000 (23,55,57,000 shares of Re. 1 each), listed on BSE.
This is a small open-market purchase by a promoter group entity, signalling mild insider confidence, but the marginal increase in stake (0.11%) is unlikely to materially move the stock price or alter control dynamics.